In this issue:
Intravenous amino acids for kidney protection during cardiac surgery
Cell-free DNA as a biomarker for kidney allograft rejection
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis
Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 agonists in patients with or without CKD
Implications of acute treatment effects on GFR for long-term kidney protection
Continuous kidney replacement therapy and survival in children and young adults
Visceral adiposity and progression of ADPKD
Effects of avenciguat on albuminuria in patients with CKD
Individualised risk of CKD progression among US adults
Post hoc analysis of the EMPA-KIDNEY trial
Twice-weekly vs thrice-weekly haemodialysis
Please login below to download this issue (PDF)